Cell Separation Market Size, Share & Trends Analysis Report By Technique (Surface Marker, Filtration), By Cell Type (Human, Animal), By Application (Cancer Research, Stem Cell Research), By Product, By End-use, And Segment Forecasts, 2024 - 2030

Cell Separation Market Size, Share & Trends Analysis Report By Technique (Surface Marker, Filtration), By Cell Type (Human, Animal), By Application (Cancer Research, Stem Cell Research), By Product, By End-use, And Segment Forecasts, 2024 - 2030


Cell Separation Market Growth & Trends

The global cell separation market size is expected to reach USD 17.43 billion by 2030, registering a CAGR of 9.94% over the forecast period, according to a new report by Grand View Research, Inc. The increasing demand for biopharmaceuticals, such as recombinant therapeutic proteins, is anticipated to boost market growth. The key players focus on the development & commercialization of advanced products to cater to the needs of researchers and healthcare professionals, which is projected to drive the demand for cell isolation products in the near future.The usage of cellular therapies is increasing for the treatment of prominent diseases, including neurological diseases, such as amyotrophic lateral sclerosis, Parkinson’s disease, spinal cord injury, and renal, skeletal, & autoimmune diseases, such as multiple sclerosis, type 1 diabetes, & Crohn's disease.

In recent years, there has been an increase in funding from government organizations for cell-based research owing to its ability to treat & manage conditions, such as cancer and other chronic diseases. The global market witnessed an upward momentum during the pandemic. For instance, in 2020, Seattle Children's Research Institute's researchers used immunoprecipitation, identified by flow cytometry (IP-FCM) test, to study the immune response of COVID-19-infected patients. As per the experiment, blood samples were collected from 24 COVID-19-positive patients to compare with blood samples of 30 healthy individuals, and the compared samples were run through the IP-FCM test.Furthermore, increasing investments and government funding have helped boost the availability of technologically advanced processes for cell isolation & biopharmaceutical production. These advancements have resulted in an increased demand for cell separation procedures, thus propelling the market growth.

Cell Separation Market Report Highlights
  • The consumables product type segment held a major revenue share of 61.94% in 2023. The increasing investments in R&D by biopharmaceutical and biotech companies are a major factor propelling the segment growth
  • The biomolecule isolation application segment held the largest share of 29.5% in 2023 since it is a pivotal step in research on cancer, HIV, and other autoimmune diseases
  • The human cell type segment is anticipated to have a significant growth rate of 12.47% during the forecast period. The fast growth is due to the rising focus on human and cancer stem cell research and varied applications of isolated human cells
  • The centrifugation technique type segment held the highest market share of 42.3% in 2023. The availability of various centrifuges provides technicians with a wide range of options catering to their specific needs
  • North America dominated the global market with a revenue share of 39.8% in 2023 owing to increasing demand for new technologies, a large pool of key players, increasing development of vaccines and therapeutics, along with advanced healthcare infrastructure
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Cell Separation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1 Rising demand for biopharmaceuticals
3.3.1.2 Increasing government funding for cell-based research
3.3.1.3 Growing focus on personalized medicine
3.3.2. Market Restraint Analysis
3.3.2.1. High cost of cell isolation products
3.3.3. Market Opportunities Analysis
3.3.3.1. Growth in biopharmaceutical outsourcing industry
3.3.3.2. Developing countries provide untapped markets for multinational players
3.3.4. Market Challenges Analysis
3.3.4.1. Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Cell Isolation/Separation
3.4. Cell Separation Market Analysis Tools
3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.4.2. Porter’s Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Cell Separation Market: Product Movement Analysis
4.2. Consumables
4.2.1. Consumables Market, 2018 to 2030 (USD Million)
4.2.2. Reagents, kits, media, and sera
4.2.2.1. Reagents, kits, media, and sera Market, 2018 to 2030 (USD Million)
4.2.3. Beads
4.2.3.1. Beads Market, 2018 to 2030 (USD Million)
4.2.4. Disposables
4.2.4.1. Disposables Market, 2018 to 2030 (USD Million)
4.3. Instruments
4.3.1. Instruments Market, 2018 to 2030 (USD Million)
4.3.2. Centrifuges
4.3.2.1. Centrifuges Market, 2018 to 2030 (USD Million)
4.3.3. Flow cytometers
4.3.3.1. Flow cytometers Market, 2018 to 2030 (USD Million)
4.3.4. Filtration systems
4.3.4.1. Filtration systems Market, 2018 to 2030 (USD Million)
4.3.5. Magnetic-activated cell separator systems
4.3.5.1. Magnetic-activated cell separator systems Market, 2018 to 2030 (USD Million)
Chapter 5. Cell Type Business Analysis
5.1. Cell Separation Market: Cell Type Movement Analysis
5.2. Human Cells
5.2.1. Human Cells Market, 2018 to 2030 (USD Million)
5.3. Animal Cells
5.3.1. Animal Cells Market, 2018 to 2030 (USD Million)
Chapter 6. Technique Business Analysis
6.1. Cell Separation Market: Technique Movement Analysis
6.2. Centrifugation
6.2.1. Centrifugation Market, 2018 to 2030 (USD Million)
6.3. Surface Marker
6.3.1. Surface Marker Market, 2018 to 2030 (USD Million)
6.4. Filtration
6.4.1. Filtration Market, 2018 to 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Cell Separation Market: Application Movement Analysis
7.2. Biomolecule Isolation
7.2.1. Biomolecule isolation Market, 2018 to 2030 (USD Million)
7.3. Cancer Research
7.3.1. Cancer research Market, 2018 to 2030 (USD Million)
7.4. Stem Cell Research
7.4.1. Stem cell research Market, 2018 to 2030 (USD Million)
7.5. Tissue Regeneration
7.5.1. Tissue regeneration Market, 2018 to 2030 (USD Million)
7.6. In vitro Diagnostics
7.6.1. In vitro diagnostics Market, 2018 to 2030 (USD Million)
7.7. Therapeutics
7.7.1. Therapeutics Market, 2018 to 2030 (USD Million)
Chapter 8. End-use Business Analysis
8.1. Cell Separation Market: End-Use Movement Analysis
8.2. Research Laboratories and Institutes
8.2.1. Research laboratories and institutes Market, 2018 to 2030 (USD Million)
8.3. Hospitals and Diagnostic Laboratories
8.3.1. Hospitals and diagnostic laboratories Market, 2018 to 2030 (USD Million)
8.4. Cell Banks
8.4.1. Cell banks Market, 2018 to 2030 (USD Million)
8.5. Biotechnology and Biopharmaceutical Companies
8.5.1. Biotechnology and biopharmaceutical companies Market, 2018 to 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Cell Separation Market Share By Region, 2023 & 2030
9.1.1. North America
9.1.1.1. North America Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
9.1.1.2. U.S.
9.1.1.2.1. Key Country Dynamics
9.1.1.2.2. Target Disease Prevalence
9.1.1.2.3. Competitive Scenario
9.1.1.2.4. Regulatory Framework
9.1.1.2.5. U.S. Cell Separation Market, 2018 to 2030 (USD Million)
9.1.1.3. Canada
9.1.1.3.1. Key Country Dynamics
9.1.1.3.2. Target Disease Prevalence
9.1.1.3.3. Competitive Scenario
9.1.1.3.4. Regulatory Framework
9.1.1.3.5. Canada Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2. EUROPE
9.1.2.1. Europe Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
9.1.2.2. UK
9.1.2.2.1. Key Country Dynamics
9.1.2.2.2. Target Disease Prevalence
9.1.2.2.3. Competitive Scenario
9.1.2.2.4. Regulatory Framework
9.1.2.2.5. UK Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2.3. Germany
9.1.2.3.1. Key Country Dynamics
9.1.2.3.2. Target Disease Prevalence
9.1.2.3.3. Competitive Scenario
9.1.2.3.4. Regulatory Framework
9.1.2.3.5. Germany Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2.4. France
9.1.2.4.1. Key Country Dynamics
9.1.2.4.2. Target Disease Prevalence
9.1.2.4.3. Competitive Scenario
9.1.2.4.4. Regulatory Framework
9.1.2.4.5. France Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2.5. Italy
9.1.2.5.1. Key Country Dynamics
9.1.2.5.2. Target Disease Prevalence
9.1.2.5.3. Competitive Scenario
9.1.2.5.4. Regulatory Framework
9.1.2.5.5. Italy Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2.6. Spain
9.1.2.6.1. Key Country Dynamics
9.1.2.6.2. Target Disease Prevalence
9.1.2.6.3. Competitive Scenario
9.1.2.6.4. Regulatory Framework
9.1.2.6.5. Spain Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2.7. Denmark
9.1.2.7.1. Key Country Dynamics
9.1.2.7.2. Target Disease Prevalence
9.1.2.7.3. Competitive Scenario
9.1.2.7.4. Regulatory Framework
9.1.2.7.5. Denmark Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2.8. Sweden
9.1.2.8.1. Key Country Dynamics
9.1.2.8.2. Target Disease Prevalence
9.1.2.8.3. Competitive Scenario
9.1.2.8.4. Regulatory Framework
9.1.2.8.5. Sweden Cell Separation Market, 2018 to 2030 (USD Million)
9.1.2.9. Norway
9.1.2.9.1. Key Country Dynamics
9.1.2.9.2. Target Disease Prevalence
9.1.2.9.3. Competitive Scenario
9.1.2.9.4. Regulatory Framework
9.1.2.9.5. Norway Cell Separation Market, 2018 to 2030 (USD Million)
9.1.3. ASIA PACIFIC
9.1.3.1. Asia Pacific Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
9.1.3.2. Japan
9.1.3.2.1. Key Country Dynamics
9.1.3.2.2. Target Disease Prevalence
9.1.3.2.3. Competitive Scenario
9.1.3.2.4. Regulatory Framework
9.1.3.2.5. Japan Cell Separation Market, 2018 to 2030 (USD Million)
9.1.3.3. China
9.1.3.3.1. Key Country Dynamics
9.1.3.3.2. Target Disease Prevalence
9.1.3.3.3. Competitive Scenario
9.1.3.3.4. Regulatory Framework
9.1.3.3.5. China Cell Separation Market, 2018 to 2030 (USD Million)
9.1.3.4. India
9.1.3.4.1. Key Country Dynamics
9.1.3.4.2. Target Disease Prevalence
9.1.3.4.3. Competitive Scenario
9.1.3.4.4. Regulatory Framework
9.1.3.4.5. India Cell Separation Market, 2018 to 2030 (USD Million)
9.1.3.5. South Korea
9.1.3.5.1. Key Country Dynamics
9.1.3.5.2. Target Disease Prevalence
9.1.3.5.3. Competitive Scenario
9.1.3.5.4. Regulatory Framework
9.1.3.5.5. South Korea Cell Separation Market, 2018 to 2030 (USD Million)
9.1.3.6. Australia
9.1.3.6.1. Key Country Dynamics
9.1.3.6.2. Target Disease Prevalence
9.1.3.6.3. Competitive Scenario
9.1.3.6.4. Regulatory Framework
9.1.3.6.5. Australia Cell Separation Market, 2018 to 2030 (USD Million)
9.1.3.7. Thailand
9.1.3.7.1. Key Country Dynamics
9.1.3.7.2. Target Disease Prevalence
9.1.3.7.3. Competitive Scenario
9.1.3.7.4. Regulatory Framework
9.1.3.7.5. Thailand Cell Separation Market, 2018 to 2030 (USD Million)
9.1.4. LATIN AMERICA
9.1.4.1. Latin America Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
9.1.4.2. Brazil
9.1.4.2.1. Key Country Dynamics
9.1.4.2.2. Target Disease Prevalence
9.1.4.2.3. Competitive Scenario
9.1.4.2.4. Regulatory Framework
9.1.4.2.5. Brazil Cell Separation Market, 2018 to 2030 (USD Million)
9.1.4.3. Mexico
9.1.4.3.1. Key Country Dynamics
9.1.4.3.2. Target Disease Prevalence
9.1.4.3.3. Competitive Scenario
9.1.4.3.4. Regulatory Framework
9.1.4.3.5. Mexico Cell Isolation/Separation, 2018 to 2030 (USD Million)
9.1.4.4. Argentina
9.1.4.4.1. Key Country Dynamics
9.1.4.4.2. Target Disease Prevalence
9.1.4.4.3. Competitive Scenario
9.1.4.4.4. Regulatory Framework
9.1.4.4.5. Argentina Cell Separation Market, 2018 to 2030 (USD Million)
9.1.5. MIDDLE EAST & AFRICA
9.1.5.1. Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
9.1.5.2. South Africa
9.1.5.2.1. Key Country Dynamics
9.1.5.2.2. Target Disease Prevalence
9.1.5.2.3. Competitive Scenario
9.1.5.2.4. Regulatory Framework
9.1.5.2.5. South Africa Cell Separation Market, 2018 to 2030 (USD Million)
9.1.5.3. Saudi Arabia
9.1.5.3.1. Key Country Dynamics
9.1.5.3.2. Target Disease Prevalence
9.1.5.3.3. Competitive Scenario
9.1.5.3.4. Regulatory Framework
9.1.5.3.5. Saudi Arabia Cell Separation Market, 2018 to 2030 (USD Million)
9.1.5.4. UAE
9.1.5.4.1. Key Country Dynamics
9.1.5.4.2. Target Disease Prevalence
9.1.5.4.3. Competitive Scenario
9.1.5.4.4. Regulatory Framework
9.1.5.4.5. UAE Cell Separation Market, 2018 to 2030 (USD Million)
9.1.5.5. Kuwait
9.1.5.5.1. Key Country Dynamics
9.1.5.5.2. Target Disease Prevalence
9.1.5.5.3. Competitive Scenario
9.1.5.5.4. Regulatory Framework
9.1.5.5.5. Kuwait Cell Separation Market, 2018 to 2030 (USD Million)
Chapter 10. COMPANY PROFILES
10.1. Company Profiles
10.1.1. THERMO FISHER SCIENTIFIC, INC
10.1.1.1. Company overview
10.1.1.2. Financial Performance
10.1.1.3. Product benchmarking
10.1.1.4. Strategic initiatives
10.1.2. MERCK KGAA
10.1.2.1. Company overview
10.1.2.2. Financial Performance
10.1.2.3. Product benchmarking
10.1.2.4. Strategic initiatives
10.1.3. BD
10.1.3.1. Company overview
10.1.3.2. Financial Performance
10.1.3.3. Product benchmarking
10.1.3.4. Strategic initiatives
10.1.4. TERUMO CORPORATION
10.1.4.1. Company overview
10.1.4.2. Financial Performance
10.1.4.3. Product benchmarking
10.1.4.4. Strategic initiatives
10.1.5. DANAHER
10.1.5.1. Company overview
10.1.5.2. Financial Performance
10.1.5.3. Product benchmarking
10.1.5.4. Strategic initiatives
10.1.6. STEMCELL TECHNOLOGIES INC.
10.1.6.1. Company overview
10.1.6.2. Financial Performance
10.1.6.3. Product benchmarking
10.1.6.4. Strategic initiatives
10.1.7. BIO-RAD LABORATORIES, INC.
10.1.7.1. Company overview
10.1.7.2. Financial Performance
10.1.7.3. Product benchmarking
10.1.7.4. Strategic initiatives
10.1.8. AGILENT TECHNOLOGIES, INC.,
10.1.8.1. Company overview
10.1.8.2. Financial Performance
10.1.8.3. Product benchmarking
10.1.8.4. Strategic initiatives
10.1.9. CORNING INCORPORATED.
10.1.9.1. Company overview
10.1.9.2. Financial Performance
10.1.9.3. Product benchmarking
10.1.9.4. Strategic initiatives
10.1.10. AKADEUM LIFE SCIENCES
10.1.10.1. Company overview
10.1.10.2. Financial Performance
10.1.10.3. Product benchmarking
10.1.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings